Related Experiment Video
Updated: May 2, 2026

06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.7K
Breast reconstruction and neoadjuvant radiotherapy (BRENAR) - study protocol for a multicenter, prospective,
Sophie H Nelissen1, Danny A Young-Afat2,3, Joeke M Felderhof4
1Department of Plastic and Reconstructive surgery, University Medical Center Utrecht, The Netherlands.
International Journal of Surgery Protocols
|August 27, 2025
Summary
Neoadjuvant radiotherapy (NART) may offer a safer alternative to post-mastectomy radiotherapy (PMRT) for breast cancer patients undergoing immediate breast reconstruction. This pilot study assesses NART
Area of Science:
- Oncology
- Plastic Surgery
- Radiotherapy
Background:
- Post-mastectomy radiotherapy (PMRT) is increasingly used for breast cancer, particularly with lymph node involvement.
- PMRT can lead to complications and poor cosmetic outcomes when combined with immediate breast reconstruction.
- Neoadjuvant radiotherapy (NART) is emerging as a potential alternative to mitigate these issues.
Purpose of the Study:
- To evaluate the safety and efficacy of NART followed by mastectomy and immediate breast reconstruction.
- To assess complication rates, patient-reported outcomes, and cosmetic results.
- To establish a foundation for future randomized controlled trials comparing NART and PMRT.
Main Methods:
- A multicenter, prospective, single-arm pilot study.
- Inclusion of breast cancer patients requiring mastectomy and NART, desiring immediate breast reconstruction (implant-based or autologous).
- Primary endpoint: complications at three months post-reconstruction; secondary endpoints: health-related quality of life (HR-QoL), cosmetic outcomes, and pathological response.
Main Results:
- This section is not available in the provided abstract.
Conclusions:
- Further evidence is needed to confirm NART as a viable alternative to PMRT for immediate breast reconstruction.
- Understanding HR-QoL and cosmetic outcomes is crucial.
- Successful outcomes could lead to a national trial comparing NART and PMRT.

